MECLIZINE 25 mg Tablet, Chewable, 14-count
by Bryant Ranch Prepack · 14 TABLET, CHEWABLE in 1 BOTTLE (71335-1215-8)
NDC 71335-1215-08
🏷️ FDA NDC (as labeled)
71335-1215-8
billing pads the package segment with a zero
This package
Contains14-count
Pack sizes10 compare ↓
Also comes in:
8 tablets 71335-1215-07
10 tablets 71335-1215-09
20 tablets 71335-1215-02
25 tablets 71335-1215-03
30 tablets 71335-1215-01
40 tablets 71335-1215-04
60 tablets 71335-1215-05
90 tablets 71335-1215-06
120 tablets 71335-1215-00
OTC
On market
Non-controlled
🗂️ Data synced Jul 24, 2026 · sources: openFDA · FDA label (DailyMed) · FDA Orange & Purple Book · First Databank · CMS NADAC, ASP, Medicare & Medicaid · RxNorm
📋 All sources & update times →
🆔 Identity & classification
FDA NDC (as labeled)
71335-1215-8
Product NDC
71335-1215
11-digit billing NDC
71335121508
RxCUI
995632
UNII
HDP7W44CIO
Application #
part336
SPL Set ID
623db9de-4224-47ce-84b7-6eaefe97290e
Established class (EPC)
Antiemetic
Physiologic effect
Emesis Suppression
DEA schedule
Non-controlled
Marketing category
OTC MONOGRAPH FINAL
Marketing status
On market
FDA listing status
Listed (active directory)
Marketing start
2018-02-01
Route
ORAL
Dosage form
TABLET, CHEWABLE
Substance
MECLIZINE HYDROCHLORIDE
GPI-14
50200050000510
GPI class
Meclizine HCl
Why two NDCs?
The FDA registers this code as 71335-1215-8 — a 5-4-1 layout, and that's what's printed on the package and shown on DailyMed. For insurance claims, every NDC is standardized to a uniform 11-digit 5-4-2 format by adding a zero to the package segment → 71335-1215-08. Same drug, same package — only the format differs.
Where does this data come from?
Identifiers from the FDA openFDA NDC Directory and Structured Product Labeling; RxCUI from RxNorm (NLM); GPI from Medi-Span; GCN / HIC / AHFS / legend from First Databank.
🏷️ RxNorm drug class
This medicine belongs to the Antiemetic class.
Pharmacologic class
Antiemetic
Drug family (ATC)
Piperazine derivatives
Where does this data come from?
Therapeutic classes from RxNorm RxClass (U.S. National Library of Medicine) — Established Pharmacologic Class (FDA), ATC drug family (WHO) and mechanism of action, matched by this product’s RxCUI.
🏭 Manufacturer & labeler
LabelerBryant Ranch Prepack
FDA applicationpart336 (OTC MONOGRAPH FINAL)
Labeler code71335
First marketedFeb 2018
Product typeHuman Otc Drug
Portfolio4,434 products on file
The labeler markets the product; the application holder owns the FDA approval. They’re often the same company but can differ (e.g. a repackager or an authorized generic). A mailing address / phone appears here when the manufacturer includes it in the product’s FDA label (not all do).
Where does this data come from?
Labeler, application holder and registered establishment from the FDA openFDA NDC Directory and Drugs@FDA; address/contact from the product’s FDA label.
🩺 Clinical
📖 What it is MedlinePlus · NLM
Meclizine is used to prevent and treat nausea, vomiting, and dizziness caused by motion sickness. It is most effective if taken before symptoms appear.
Read the full MedlinePlus article ↗📗 Our plain-language guide HelloPharmacist
- Meclizine is mainly used to prevent and treat the nausea, vomiting, and dizziness that comes with motion sickness — whether you're on a boat, in a car, or on a plane. It's also use...
- For the best chance of preventing motion sickness, take meclizine about one hour before you start traveling. After that first dose, you can take it once every 24 hours as needed fo...
- Yes, drowsiness is the most common side effect — it's actually worth planning around. Avoid driving or operating heavy machinery until you know how it affects you. And definitely s...
- This one requires a conversation with your doctor. Human studies haven't clearly linked meclizine to birth defects, but animal studies did show fetal harm at doses similar to what...
Patient education
Supplement & herbal interactions
Where does this data come from?
Plain-language summary from MedlinePlus (U.S. National Library of Medicine); supplement & herbal interactions and nutrient depletion data from the Natural Medicines database; our full guide is HelloPharmacist editorial content.
💬 Questions about Meclizine HCl 25mg?
Ask a pharmacist →
Ask a licensed pharmacist directly — free, answered by our team.
🧪 Inactive Ingredients / Excipients
Inactive ingredients, also called excipients, are components of the drug product other than the active ingredient. They may include fillers, dyes, coatings, preservatives, flavors, or other formulation ingredients.
Loading inactive ingredients from the official FDA label in the background. No external source is being called by this page request.
Where does this data come from?
Source: official FDA Structured Product Labeling (SPL) via DailyMed and the openFDA label index. Structured
IACT rows and label-wide narrative are kept separate; availability and product-level specificity depend on the submitted label.Inactive ingredient FAQ
Are inactive ingredients the same for every manufacturer?
No. Inactive ingredients can differ by manufacturer, dosage form, strength, and package / product version.
Why might an inactive ingredient be missing?
Some SPLs do not provide a complete structured inactive-ingredient list, and older or unusual labels may only include the information in narrative text.
Can inactive ingredients matter?
Yes. They can matter for allergies, intolerances, dyes, gluten / lactose concerns, preservatives, and formulation differences — but confirm with a pharmacist or the manufacturer when it’s clinically important.
💲 Pricing
A drug doesn't have one price. Each row is a different public payment system, and none is what you'd pay at the counter — that depends on your insurance. The ⓘ on each row explains what it measures.
| Price system | Per each | Per package |
|---|---|---|
| Retail pharmacies payNADAC · weekly | Not in the retail survey — common for institutional, discontinued, or low-volume packs. | |
| Medicaid paysCMS SDUD · 12 mo | No recent Medicaid claims on file for this NDC — rare and low-volume NDCs are suppressed in the public data. | |
| Medicare drug plans payPart D · quarterly | No Part D plan price is available for this NDC in our data. | |
ℹ️
No price is published for this exact package yet. CMS surveys NADAC per package size, so a different pack of the same drug often has one.
Try another pack size:
8 tablets
10 tablets
20 tablets
25 tablets
30 tablets
40 tablets
60 tablets
90 tablets
120 tablets
Where does this data come from?
NADAC (National Average Drug Acquisition Cost) is the CMS weekly pharmacy-acquisition-cost survey — what pharmacies pay. ASP (Average Sales Price) is the CMS Medicare Part B drug-payment file, published quarterly. Medicaid pays is computed by us from CMS State Drug Utilization Data (total reimbursed ÷ units, trailing 12 months) — gross of rebates and inclusive of dispensing fees, so it reflects what Medicaid paid, not an acquisition cost. Medicare drug plans pay is the median negotiated point-of-sale unit cost across plans listing this NDC in the CMS quarterly Prescription Drug Plan pricing files, before rebates. The VA pays is the federal contract price (FSS, and the statutory Big 4 ceiling where listed) from the VA National Acquisition Center pharmaceutical price file. All are free public government data; each measures a different payer, so the figures are not directly comparable.
🔁 Therapeutic equivalents
| Product | Labeler | Pack | NADAC/unit | TE | Status | Price vs. this |
|---|---|---|---|---|---|---|
| Meclizine Hydrochloride 25 mg 00536-1299-01 | Rugby | 100 tablets | $0.033 | — | Availability likely | — |
| Meclizine HCl 25 mg 16571-0824-01 | Rising | 100 tablets | $0.033 | — | Availability likely | — |
| Motion Sickness Relief 25 mg 46122-0774-51 | Amerisource | 8 tablets | $0.033 | — | Availability likely | — |
| Motion-Time Chewable 25 mg/251 49483-0333-01 | Time-Cap | 100 tablets | $0.033 | — | Availability likely | — |
| Meclizine HCl 25 mg 68001-0529-00 | BluePoint | 100 tablets | $0.033 | — | Availability likely | — |
| Motion Sickness 25 mg 70677-1290-01 | Strategic | 100 tablets | $0.033 | — | Availability likely | — |
| Travel ease 25 mg 83324-0027-16 | Chain | 8 tablets | $0.033 | — | Availability likely | — |
| Motion Sickness Relief 25 mg 00363-4040-21 | Walgreen | 8 tablets | — | — | FDA listed | — |
| Meclizine Hydrochloride 25 mg 00363-5172-07 | Walgreen | 12 tablets | — | — | FDA listed | — |
| Motion Sickness Relief 25 mg 11822-4040-01 | Rite | 8 tablets | — | — | FDA listed | — |
| Meclizine 25 mg 16103-0387-08 | Pharbest | 100 tablets | — | — | FDA listed | — |
| Meclizine Hydrochloride 25 mg 16571-0663-01 | Rising | 100 tablets | — | — | FDA listed | — |
| Meclizine HCL 25 mg 17714-0115-01 | Advance | 100 tablets | — | — | FDA listed | — |
| Meclizine 25 mg 37835-0202-01 | Bi-Mart | 100 tablets | — | — | FDA listed | — |
| Meclizine 25 mg 43063-0804-01 | PD-Rx | 100 tablets | — | — | FDA listed | — |
| Meclizine Hydrochloride 25 mg 50090-5496-00 | A-S | 30 tablets | — | — | FDA listed | — |
| Meclizine Hydrochloride 25 mg 50090-5952-00 | A-S | 30 tablets | — | — | FDA listed | — |
| Motion Sickness Relief 25 mg 51013-0322-54 | PuraCap | 2 tablets | — | — | FDA listed | — |
| Motion Sickness Relief 25 mg 51316-0404-21 | CVS | 8 tablets | — | — | FDA listed | — |
| Motion Sickness 25 mg 51316-0441-21 | CVS | 8 tablets | — | — | FDA listed | — |
| Meclizine HCL 25 mg 54738-0025-01 | Richmond | 100 tablets | — | — | FDA listed | — |
| Dramamine 25 mg 63029-0906-12 | Medtech | 12 tablets | — | — | FDA listed | — |
| Dramamine 25 mg 63029-0913-12 | Medtech | 12 tablets | — | — | FDA listed | — |
| Dramamine 25 mg 63029-0914-12 | Medtech | 12 tablets | — | — | FDA listed | — |
| Bonine 25 mg 65197-0275-02 | WellSpring | 2 tablets | — | — | FDA listed | — |
| Bonine 25 mg 65197-0296-08 | WellSpring | 8 tablets | — | — | FDA listed | — |
| Bonine 25 mg 65197-0297-08 | WellSpring | 8 tablets | — | — | FDA listed | — |
| Meclizine Hydrochloride 25 mg 68071-2574-02 | NuCare | 20 tablets | — | — | FDA listed | — |
| Meclizine HCL 25 mg 68788-7982-01 | Preferred | 10 tablets | — | — | FDA listed | — |
| Meclizine HCl 25 mg 68788-8529-01 | Preferred | 10 tablets | — | — | FDA listed | — |
| Meclizine HCL 25 mg 69618-0028-01 | Reliable | 100 tablets | — | — | FDA listed | — |
| Motion Sickness Relief 25 mg 69842-0395-54 | CVS | 2 tablets | — | — | FDA listed | — |
| Meclizine HCL 25 mg 71205-0606-30 | Proficient | 30 tablets | — | — | FDA listed | — |
| Meclizine 25 mgthis 71335-1215-08 | Bryant | 14 tablets | — | — | FDA listed | — |
| Meclizine HCL 25 mg 71335-1607-00 | Bryant | 120 tablets | — | — | FDA listed | — |
| Meclizine Hydrochloride 25 mg 71335-2177-00 | Bryant | 120 tablets | — | — | FDA listed | — |
| Meclizine HCl 25 mg 71335-9751-00 | Bryant | 120 tablets | — | — | FDA listed | — |
| Meclizine HCL 25 mg 71610-0528-30 | Aphena | 30 tablets | — | — | FDA listed | — |
| Meclizine Hydrochloride 25 mg 71610-0836-30 | Aphena | 30 tablets | — | — | FDA listed | — |
| Meclizine Hydrochloride 25 mg 72789-0250-12 | PD-Rx | 12 tablets | — | — | FDA listed | — |
| Meclizine 25 mg 80513-0421-02 | Advanced | 200 tablets | — | — | FDA listed | — |
About this product: other versions of the same ingredient, strength and form are listed above, least expensive first, with FDA equivalence ratings where available.
Where does this data come from?
Equivalents are other NDCs of the same ingredient, form and route from the openFDA NDC Directory, ranked least-expensive-first by NADAC. Therapeutic-equivalence (AB) ratings come from the FDA Orange Book; biologics use the FDA Purple Book for biosimilar & interchangeable status.
⏳ Availability & generic status
🏛️
2018
On the market since
Feb 2018
📍
2026
Currently FDA-listed
8 years listed
🔒
·
No generic listed yet
brand only
ℹ️No FDA-approved generic found
We did not find an FDA-approved generic match for this exact strength, form and route.
Where does this data come from?
Patents and exclusivity from the FDA Orange Book (small-molecule drugs), refreshed from public FDA data. Generic launch timing is an estimate, not a guarantee.
📦 Packaging — all sizes for this product
| Package NDC | Description | Marketing start | Status |
|---|---|---|---|
| 71335-1215-00 | 120 TABLET, CHEWABLE in 1 BOTTLE (71335-1215-0) | 2019-05-20 | Active |
| 71335-1215-01 | 30 TABLET, CHEWABLE in 1 BOTTLE (71335-1215-1) | 2019-05-20 | Active |
| 71335-1215-02 | 20 TABLET, CHEWABLE in 1 BOTTLE (71335-1215-2) | 2019-05-20 | Active |
| 71335-1215-03 | 25 TABLET, CHEWABLE in 1 BOTTLE (71335-1215-3) | 2019-05-20 | Active |
| 71335-1215-04 | 40 TABLET, CHEWABLE in 1 BOTTLE (71335-1215-4) | 2019-05-20 | Active |
| 71335-1215-05 | 60 TABLET, CHEWABLE in 1 BOTTLE (71335-1215-5) | 2019-05-20 | Active |
| 71335-1215-06 | 90 TABLET, CHEWABLE in 1 BOTTLE (71335-1215-6) | 2019-05-20 | Active |
| 71335-1215-07 | 8 TABLET, CHEWABLE in 1 BOTTLE (71335-1215-7) | 2019-05-20 | Active |
| 71335-1215-08 You're viewing this | 14 TABLET, CHEWABLE in 1 BOTTLE (71335-1215-8) | 2019-05-20 | Active |
| 71335-1215-09 | 10 TABLET, CHEWABLE in 1 BOTTLE (71335-1215-9) | 2019-05-20 | Active |
You're viewing one of 10 pack sizes for this product.
Pack size FAQ
What quantity is in NDC 71335-1215-08?
NDC 71335-1215-08 is a 14-count package — 14 tablet, chewable in 1 bottle.
What is the difference between NDC 71335-1215-08 and NDC 71335-1215-07?
Both are MECLIZINE 25 mg Tablet, Chewable — the drug itself is identical. NDC 71335-1215-08 is the 14-count package, while NDC 71335-1215-07 is the 8 tablets package.
What NDC number is used to bill for this package of MECLIZINE 25 mg Tablet, Chewable?
Bill NDC 71335-1215-08 — the 11-digit billing format is 71335121508. Pharmacy and medical claims use the 11-digit form; the FDA label may print a shorter form of the same code.
🧭 About this NDC listing & data coverage
Over-the-counter (OTC) product
What data is (and isn’t) available for this NDC — tap to expand
| NDC identity (package / product / labeler codes) | ✓ Available |
| Labeler | ✓ Available |
| Product & package description | ✓ Available |
| Marketing category & status | ✓ Available |
| Active ingredient / dosage form / route | ✓ Available |
| FDA label (SPL via DailyMed) | ✓ Available |
| Package photos | ✓ Available |
| Inactive ingredients (structured) | — Not published for this NDC The labeler did not submit a structured excipient list, or no SPL is available. |
| NADAC pharmacy acquisition price (CMS) | — Not published for this NDC CMS publishes NADAC only for NDCs reported in its retail-pharmacy survey. |
| Orange Book / therapeutic-equivalence data | — Not published for this NDC Applies only to products approved under an NDA/ANDA; many listings are out of scope. |
| HCPCS J-code billing crosswalk | — Not published for this NDC Most self-administered / retail products have no J-code — that is normal. |
| Medicaid utilization (CMS SDUD) | — Not published for this NDC CMS reports utilization only for NDCs with Medicaid claims above its privacy threshold. |
“Not published” reflects what the public FDA / CMS / NLM sources provide for this exact package code — it is a property of the data feeds, not a judgment about the product.
Questions about this listing
Is this NDC FDA-approved?
An NDC listing does not by itself establish FDA approval — the NDC Directory records that a product is listed with FDA, not that it was reviewed and approved. This listing's marketing category is "Otc Monograph Final". Products approved under an application carry an NDA, ANDA, or BLA number.
Why is there no price listed?
The pricing shown on our NDC pages comes from CMS NADAC, a voluntary survey of retail community pharmacy invoices. CMS does not publish a NADAC for every NDC — packages outside the retail survey (institutional and hospital products, bulk packages, discontinued items, and many OTC items) may never receive one. A missing price reflects the survey's scope, not this product's actual cost, and does not mean the product is free or unavailable.
Is the NDC printed on the package the same as the 11-digit billing NDC?
Yes, they identify this exact package in different formats. The FDA registers it as 71335-1215-8, which is what is printed on the packaging and shown on DailyMed. Insurance claims use a fixed 11-digit 5-4-2 format, so the short segment is padded with a leading zero: 71335-1215-08, written without dashes as 71335121508. The Identity section at the top of this page lists every form of this code.
What do the three segments of this NDC mean?
In 71335-1215-08, the first segment (71335) is the labeler code FDA assigned to Bryant Ranch Prepack; the middle segment (1215) identifies this specific product — its ingredient, strength, and dosage form; and the last segment (08) identifies this exact package size and type. Together they name one specific package of one specific product.
Is this package still being marketed?
Yes, per the latest FDA NDC Directory data on this page: this package is listed as actively marketed, with no marketing end date reported by Bryant Ranch Prepack. Listing status can change — the directory data on this page refreshes weekly.
Does this product come in other package sizes?
Yes — the FDA directory lists 9 other package presentations of this same product, including 8 tablets (71335-1215-07), 10 tablets (71335-1215-09), 20 tablets (71335-1215-02). Each has its own NDC and its own page — see the package list near the top of this page.
Who lists this product with the FDA?
Bryant Ranch Prepack is the labeler of record for this NDC — the company under whose FDA-assigned code the package is listed. The labeler may be the manufacturer itself or a distributor marketing the product under its own code.
Do I need a prescription for this product?
This NDC is listed with FDA as an over-the-counter product, so it does not require a prescription. Follow the package directions, and ask your pharmacist if you are unsure whether it is right for you.
This page identifies an FDA-listed package (the NDC) and reports public regulatory and pricing data about the listing. It is reference information, not a medical recommendation — talk to your pharmacist or prescriber about your own medication.
Where does this data come from?
Listing facts (marketing category, packager status, marketing dates) from the FDA openFDA NDC Directory; label availability from DailyMed; pricing coverage from CMS NADAC; equivalence scope from the FDA Orange Book.
📄 FDA label — Drug Facts FDA SPL
The complete FDA label for this product — the official Drug Facts labeling, verbatim, section by section. Jump with a chip, search within the label, or expand everything.
🎯 Indications and Usage
⏱️ Dosage and Administration
⚠️ Warnings
📦 How Supplied / Storage and Handling
📦 Storage and Handling
🧪 Active Ingredient
🧪 Inactive Ingredients
🎯 Purpose
🎯 Indications and Usage ▾
Uses prevents and treats nausea, vomiting or dizziness associated with motion sickness
⏱️ Dosage and Administration ▾
Directions doage should be taken 1 hour before travel starts Adults and children 12 years and over take 1 or 2 tablets once daily or as directed by doctor
⚠️ Warnings ▾
Warnings Do not use for children under 12 years of age unless directed by a doctor. Do not take unless directed by a doctor if you have glaucoma trouble urinating due to an enlarged prostate gland a breathing problem such as emphysema or chronic bronchitis Do not take if you are taking sedatives or tranquilizers, without first consulting your doctor. When using this product do not exceed recommended dosage drowsiness may occur alcohol, sedatives, and tranquilizers may increase drowsiness avoid alcoholic drinks be careful when driving a motor vehicle or operating machinery If pregnant or breast-feeding, ask a health professional before use.
Keep out of reach of children. In case of overdose, get medical help or contact a Poison Control Center right away.
📦 How Supplied / Storage and Handling ▾
HOW SUPPLIED Product: 71335-1215 NDC: 71335-1215-0 120 TABLET, CHEWABLE in a BOTTLE NDC: 71335-1215-1 30 TABLET, CHEWABLE in a BOTTLE NDC: 71335-1215-2 20 TABLET, CHEWABLE in a BOTTLE NDC: 71335-1215-3 25 TABLET, CHEWABLE in a BOTTLE NDC: 71335-1215-4 40 TABLET, CHEWABLE in a BOTTLE NDC: 71335-1215-5 60 TABLET, CHEWABLE in a BOTTLE NDC: 71335-1215-6 90 TABLET, CHEWABLE in a BOTTLE NDC: 71335-1215-7 8 TABLET, CHEWABLE in a BOTTLE NDC: 71335-1215-8 14 TABLET, CHEWABLE in a BOTTLE NDC: 71335-1215-9 10 TABLET, CHEWABLE in a BOTTLE
📦 Storage and Handling ▾
Other information Tamper Evident: do not use if safety seal under cap is broken or missing store at room temperature 20°-25°C (68°-77°F)
🧪 Active Ingredient ▾
Active ingredient (in each tablet) Meclizine HCl 25mg
🧪 Inactive Ingredients ▾
Inactive ingredients Croscarmellose sodium, dextrose, FD&C Red#40, flavor, magnesium stearate, microcrystalline cellulose, silicon dioxide, sodium saccharine, stearic acid
🎯 Purpose ▾
Purpose Antiemetic
No label section mentions that — try another word, or open the full label on DailyMed below.
Source: FDA Structured Product Labeling, mirrored from DailyMed / openFDA.
Prefer the government’s original formatting? View this label on DailyMed ↗
For educational and professional reference only — not medical advice. Pricing reflects published
NADAC and CMS ASP (free public data) and may differ from your acquisition cost; always verify before billing or dispensing.